Implanted biomaterials and biomedical devices generally induce foreign body reaction and end up with encapsulation by a dense avascular fibrous layer enriched in extracellular matrix. Fibroblasts/myofibroblasts are thought to be the major cell type involved in encapsulation, but it is unclear whether and how stem cells contribute to this process. Here we show, for the first time, that Sox10+ adult stem cells contribute to both encapsulation and microvessel formation. Sox10+ adult stem cells were found sparsely in the stroma of subcutaneous loose connective tissues. Upon subcutaneous biomaterial implantation, Sox10+ stem cells were activated and recruited to the biomaterial scaffold, and differentiated into fibroblasts and then myofibroblasts. This differentiation process from Sox10+ stem cells to myofibroblasts could be recapitulated in vitro. On the other hand, Sox10+ stem cells could differentiate into perivascular cells to stabilize newly formed microvessels. Sox10+ stem cells and endothelial cells in three-dimensional co-culture self-assembled into microvessels, and platelet-derived growth factor had chemotactic effect on Sox10+ stem cells. Transplanted Sox10+ stem cells differentiated into smooth muscle cells to stabilize functional microvessels. These findings demonstrate the critical role of adult stem cells in tissue remodeling and unravel the complexity of stem cell fate determination.
Biomaterials and biomedical devices have been widely used in clinical applications, such as drug releasing devices1,2, glucose sensors3, vascular grafts4,5, bone and cartilage grafts6,7. The implants generally induce foreign body reaction and end up with encapsulation with a thick avascular fibrous layer composed of dense extracellular matrix around implants1. Encapsulation can be detrimental to some medical devices including drug releasing systems and glucose sensors, which blocks the free movement of molecules between the devices and host tissues, thus impairs their performances. Much effort has been made to modify biomaterials to reduce capsular thickness and/or enhance angiogenesis for better integration into host tissues1,8,9,10. On the other hand, encapsulation could also be beneficial for some implants such as vascular, bone and cartilage grafts. Upon transplantation, host cells are recruited to the biomaterial grafts from surrounding tissues, form a capsule layer, and infiltrate into the grafts if they have a porous structure, which promotes their integration into host tissues6,11,12.
Although encapsulation is an important phenomenon, there are few studies on the cellular origins of encapsulation. Traditionally, fibroblasts are thought to be the major cells contributing to biomaterials encapsulation1. Encapsulation is a fibrosis process and it shares the common characteristics of organ fibrosis or scar formation: the accumulation of extracellular matrix and the degeneration of microvessels13. Most studies on cellular origins of fibrosis are from organ fibrosis14. For example, during skin wound healing and scar formation, fibroblasts are activated to proliferate, differentiate into myofibroblasts, secrete excessive extracellular matrix, express smooth muscle α-actin (ACTA2) and apply contractive force to close the wound14. Studies from organ fibrosis also reported that perivascular cells were another important source of myofibroblasts15,16,17,18,19. However, the relationship between fibroblasts and perivascular cells, and the involvement of other stem cells remain to be elucidated.
In recent years, several research groups including our laboratory reported that Sox10+ adult stem cells existed in multiple tissues including large blood vessels walls and surrounding tissues, which could be recruited to vascular graft contributing to tissue remodeling5,20. We sought to investigate whether and how Sox10+ stem cells participate in biomaterials encapsulation in general. Here we showed that Sox10+ adult stem cells were found in the stroma of subcutaneous loose connective tissues. We utilized in vivo subcutaneous biomaterial implantation, in vitro stem cell culture, ex vivo tissue explant culture, in vivo stem cell transplantation and two-photon live animal microscopy experiments and showed that Sox10+ adult stem cells differentiated into fibroblasts at early stages of biomaterial implantation, and then differentiated into myofibroblasts contributing to encapsulation, or perivascular cells supporting angiogenesis. The same cell population can give rise to both fibrotic/capsule tissues and microvessels depending on local microenvironment, which demonstrates the critical role of adult stem cells in tissue remodeling and unravels the complexity of stem cell fate determination.
Sox10+ cells were found in the stroma of subcutaneous loose connective tissues and activated upon biomaterial implantation
To investigate whether Sox10+ adult stem cells contribute to biomaterial encapsulation, we prepared poly(L-lactic acid) (PLLA) scaffold membranes (Fig. 1a) and implanted them into multiple subcutaneous spaces of rats (Fig. 1b). Immunostaining showed sparse Sox10+ cells (<2%) and fibroblasts (~5%, expressing fibroblast-specific protein 1 (FSP1), a fibroblast marker) in the stroma of subcutaneous loose connective tissues before implantation (Fig. 1c; Figure S1). These Sox10+ cells did not express FSP1 (Fig. 1c), suggesting that they were a different stromal cell population from fibroblasts. One-week post-implantation, we found many Sox10+ cells (~20%) around the scaffold, and more than 90% of them showed FSP1 expression (Fig. 1d,e). We found similar phenomena in the scaffolds implanted into multiple subcutaneous sites of rats (Fig. 1b). These results are consistent with the traditional knowledge that fibroblasts are activated to proliferate upon injury. In addition, it demonstrates the connection between Sox10+ cells and fibroblasts in vivo.
Sox10+ cells are a precursor of fibroblasts
To determine the relationship of Sox10+ and FSP1+ cells, we performed conventional primary fibroblasts culture. Subcutaneous loose connective tissues were harvested from normal rats, cut into small pieces and put into culture dishes in the medium supplemented with 10% fetal bovine serum (FBS). The cells migrated from the tissues and proliferated with a classic fibroblast cell shape. After one week of culture, the primary cells were passaged to new dishes and used for analysis. By immunostaining, we found that most of the cells were Sox10+/FSP1+ (Fig. 2a; Figure S2a), similar to the cells around implanted scaffolds (Fig. 1d). Considering that high concentration of FBS may induce cell differentiation quickly, we switched to a custom-made chick embryo extract (CEE) medium. We obtained a Sox10+ population in CEE medium, among which about 25% of cells expressed FSP1 (Fig. 2b,c; Figure S2b), suggesting that CEE medium could slow down the differentiation of Sox10+ cells.
To isolate single Sox10+/FSP1− cells from Sox10+/FSP1+ cells, we plated the mixed cell population at very low density (~100 cells per 100-mm dish), and found most of them could form colonies after 10-day culture in CEE medium (Figure S3). By immunostaining, we found that, some colonies consisted of all Sox10+/FSP1+ cells while others had all Sox10+ cells with gradient expression pattern of FSP1 as the lowest level in the center and the highest at the periphery (Fig. 2d–f; Figure S4). Mixture of these colonies were further passaged for additional analysis of single-cell colony formation in the medium with 10% FBS, which may induce spontaneous differentiation. We found that all colonies became FSP1+ cells with few Sox10+ ones after two passages (Figure S5), indicating that differentiated fibroblasts lost Sox10 expression. These results suggest that Sox10+ cells are a precursor of fibroblasts.
Sox10+ cells are multipotent stem cells
We further characterized the stem cell properties of Sox10+ cells in vitro. By quantitative real-time polymerase chain reaction, we found the cultured cells had high telomerase activity compared to wounded and normal tissue (Fig. 3a). By flow cytometry and immunostaining (Fig. 3b–e), we found Sox10+ cells expressed markers of mesenchymal stem cells, such as CD29, CD44, CD73, CD90 and Snail. They also expressed neural crest stem cell markers, P75 and nestin, but not c-Kit, ADAM12, CD146 or NG2. They did not express CD45 indicating that they were not derived from hematopoietic lineage. In specific induction media, Sox10+ cells could differentiate into chondrogenic (Alcian blue), osteogenic (Alizarin red) and adipogenic (Oil red) cells (Fig. 3f–h). In the medium with 10% FBS and 10 ng/ml transforming growth factor β1 (TGFβ1), they differentiated into myofibroblasts (Vimentin+ and smooth muscle α-actin+/ACTA2+) and smooth muscle cells (SMCs) (ACTA2+, Calponin1/CNN1+, Myocardin+, Smoothelin+ and smooth muscle myosin heavy chain+/MYH11+) (Fig. 3i–n).
Taken together, these results suggest that there are Sox10+ adult stem cells in the stroma of subcutaneous loose connective tissues, which can be activated to proliferate and differentiate into fibroblasts at early stages of biomaterial implantation. They also have the potential to differentiate into myofibroblasts and SMCs in vitro.
Sox10+ adult stem cells contribute to both encapsulation and microvascularization after transplantation in vivo
To further investigate Sox10+ adult stem cell fate in vivo, we performed stem cell transplantation experiments. Our flow cytometry results showed that Sox10+ stem cells also expressed P75, which is a surface marker for neural crest stem cells and can be conveniently used for live cell sorting. Thus we used P75 to further purify the population for the following experiments. The green fluorescent protein (GFP)+/Sox10+/P75+ cells were isolated from the first passage of Sox10+ cells from the subcutaneous loose connective tissues of GFP-rats using P75 as the marker for magnetic cell separation, and were subsequently transplanted into the subcutaneous space of immunodeficient mice by Matrigel plug assay. After two weeks, the Matrigel plugs were harvested for immunohistology. We found that, in the periphery of the Matrigel plug, the GFP+ cells were elongated, aligned parallel to each other, had strong ACTA2 signal, and formed a capsule layer wrapping around the Matrigel plug, indicating that they had differentiated into myofibroblasts (Fig. 4a and b; Figure S6). It was a surprise that, in the center of the Matrigel plug, the GFP+ cells formed tubular structures and also expressed ACTA2, suggesting that they might have differentiated into perivascular cells (Fig. 4a and c; Figure S6).
To further examine the role of Sox10+ stem cells in vascular regeneration, we performed Matrigel tube formation assay and found GFP+/Sox10+/P75+ stem cells formed microvessels when co-cultured with vascular endothelial cells (Fig. 5a). By transwell cell migration assay, we found that they had a chemotactic response to platelet-derived growth factor BB (PDGF-BB), an important growth factor involved in microvessel formation (Fig. 5b). In an ex vivo three-dimensional tissue explant culture model, Sox10+ cells co-migrated with vascular endothelial cells and newly sprouting microvessels (Fig. 5c). Thus, in vivo, in vitro and ex vivo results showed that Sox10+ adult stem cells contributed to both encapsulation and microvascularization.
We also examined other vascular markers of GFP+ vessels in the center of Matrigel plug and found GFP+ mural cells wrapped around CD31+ endothelial cells, expressed NG2 and MYH11 (Fig. 6a–c; Figure S7). It was interesting that these GFP+ microvessels had uniform expression of ACTA2 and NG2, but had a mosaic pattern of MYH11 expression (Figs 4 and 6; Figure S7), suggesting that they were in the process of maturation into SMCs. To examine whether the microvessels formed by GFP+/Sox10+ stem cells are functional, we implanted them into the skinfold chamber of immunodeficient mice (Figure S8) and imaged them by two-photon microscopy. By tail vein injection of Dextran-Rhodamine, we found the microvessels formed by GFP+ cells were perfused with the dye and thus were functional (Fig. 6d).
Fibroblast as an intermediate cell type in the process of perivascular cell maturation
To investigate the cell fate decision between fibroblasts and vascular mural cells, we performed immunostaining of GFP+ microvessels in the Matrigel plug. We found that the GFP+ cells lost Sox10 expression two-week post-implantation. There were GFP+/ACTA2+/FSP1+ mural cells in some microvessels (Fig. 7a), but some GFP+/ACTA2+ mural cells already lost FSP1 expression (Fig. 7b). To investigate the temporal dynamics of FSP1 expression, we induced Sox10+ stem cells to differentiate into SMCs in vitro as mentioned before (Fig. 3i–n). We found that most of the cells expressed FSP1 with or without ACTA2 expression (FSP1+/ACTA2−, or FSP1+/ACTA2+) at early stages (3 days), however at late stages (14 days), most of the cells were FSP1−/ACTA2+ and only a few FSP1+ cells remained (Fig. 7c,d). These results suggest that FSP1+ mural cells may be an intermediate cell type during perivascular cell maturation.
Previous studies show that Sox10 is a marker of neural crest cells during embryonic development, which give rise to most craniofacial tissues including connective tissues and vascular SMCs21,22. In recent years, Sox10+ stem cells have been reported to exist in multiple adult tissues, including inferior turbinate23, periodontal ligament24, hair follicle25,26, mammary epithelium27, and bone marrow28. Sox10 could also promote tumor formation29. In our previous work, Sox10+ adult stem cells were found in large blood vessel walls and surrounding tissues, and were recruited to vascular grafts contributing to vascular remodeling5,20,30. In this study, we further demonstrate that Sox10+ stem cells have a more universal distribution and can be found in the stroma of subcutaneous loose connective tissues, which could contribute to both encapsulation/fibrosis and microvascularization. Our studies, together with others, indicate that Sox10+ stem cells play important roles in adult tissue remodeling.
Although biomedical devices have been widely used in clinical applications, there remains a high failure rate9. Encapsulation is one of the major factors that cause the failure of implanted devices1,9. Most research groups have been focusing on modifying biomaterial composition, surface, structure or morphology to reduce capsule thickness and/or enhance angiogenesis1,9,10. On the contrary, some other research groups harnessed biomaterial encapsulation to make tubular structures composed of fibrous capsule tissues as vascular grafts31. Given the importance of biomaterial encapsulation, however, little attention has been paid on its cellular origins. Traditionally, fibroblasts are thought to be the major cells contributing to encapsulation, which is similar to skin wound healing and scar formation1,14. In this study, we found that Sox10+ adult stem cells in the stroma of subcutaneous loose connective tissues are a precursor of proliferating fibroblasts and myofibroblasts during encapsulation. Moreover, Sox10+ adult stem cells can contribute to microvascularization by differentiating into perivascular cells (Fig. 4). To our knowledge, this is the first report that a type of adult stem cells can directly contribute to both encapsulation/fibrosis and microvascularization.
Myofibroblasts and vascular SMCs are similar as they both express ACTA2 and produce contractile force14,32. A distinction is their tissue locations, as myofibroblasts usually exist in dense connective tissues enriched in extracellular matrix, while vascular SMCs wrap around blood vessels. It was reported that the ACTA2 gene expression was regulated differently in these two types of cells33. Some markers are used to separate these two cell types, such as MYH11 and Smoothelin, which are expressed in SMCs, but not in myofibroblasts34,35. However, it was also reported that differentiating myofibroblasts could express SMC markers CNN1, Smoothelin and MYH1136. Our study suggests that Sox10+ stem cells may go through a common fibroblast-like stage and further differentiate into myofibroblasts or SMCs, depending on the microenvironment.
At present, fibroblasts have not been well defined and previous observation and concept of fibroblasts might include cells at various stages of differentiation as they appear quite heterogeneous. They are mostly described based on cell morphology and their tissue location: they are embedded in the stroma of connective tissues, have a spindle shape, and are not vascular, epithelial or inflammatory cells37,38. A few markers have been proposed for identifying fibroblasts, including FSP1. It was first reported as a fibroblast marker by Strutz et al. and was found to be able to distinguish fibroblasts from epithelial cells39. FSP1 has also been used as an early marker for epithelial-mesenchymal transition and may play important roles during fibrosis39,40,41,42. Arteriole SMCs were found to express FSP1 in benign nephrosclerosis samples and thought to contribute to fibrosis process43. In contrast to the traditional opinion that FSP1 expression is indicative of fibrosis, our results showed that FSP1+ cells still retain the capability of forming microvessels. This result is consistent with the reports that FSP1 protein could promote angiogenesis during tumor formation44,45,46 and fibroblasts could stabilize in vitro engineered microvessels47. In our stem cell transplantation experiment in vivo, GFP+/Sox10+ stem cells differentiated into two types of perivascular cells: FSP1+/ACTA2+ and FSP1−/ACTA2+. During Sox10+ stem cells’ differentiation into SMCs in vitro, FSP1 expression was decreased in the late stages. These results indicate that FSP1 might be an intermediate stage marker during the differentiation of Sox10+ stem cells into perivascular cells or SMCs.
As encapsulation/fibrosis and microvascularization lead to distinct clinical outcomes, understanding the underlying regulatory mechanisms is of great importance. These two processes seem to compete with each other during tissue regeneration, as encapsulation/fibrosis is usually accompanied by microvascular degeneration1,13. However, there is evidence that the cells involved in these two processes may be related. For example, pericytes or perivascular progenitor cells17,18,19 and SMCs43 have been reported to give rise to myofibroblasts during fibrosis. On the other hand, there has also speculation that myofibroblasts, when put in the right microenvironment, such as the media layer of large blood vessel walls, might differentiate into SMCs35, suggesting the possibility of reciprocal transformation of the two processes. Our study showed that even the cells expressing FSP1, a traditionally recognized fibroblast/fibrosis marker, could form microvessels. The microenvironment of the cells (in this study, cell location relative to a Matrigel plug) probably played a key role in cell fate determination.
In conclusion, this study provides a novel mechanism that Sox10+ adult stem cells in the stroma of subcutaneous loose connective tissues are a common precursor of fibroblasts/myofibroblasts and perivascular cells. These adult stem cells can first differentiate into fibroblast-like cells at early stages of biomaterials implantation, and then into myofibroblasts promoting encapsulation/fibrosis, or perivascular cells supporting microvessels. This study is focused on Sox10+ adult stem cells and their functions in encapsulation/fibrosis and microvessel regeneration. Indeed, this complex remodeling process also involves other cell types such as inflammatory, microvascular and other types of stem cells. Further studies are warranted to investigate how different cells, extracellular matrices as well as other microenvironmental factors interact with each other to determine cell fate in tissue remodeling.
Materials and Methods
Fabrication of biomaterial scaffold membrane
Microfiber scaffold membranes were fabricated by using PLLA (MW 67,400, Sigma Aldrich) as previously reported5,48. The polymer was completely dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, Aladdin) at the concentration of 19% (w/v). Microfibrous scaffold were made by electrospinning. The negative voltage of 4.5 kV was applied to the collecting plate, and a positive voltage of 4 kV was applied to the spinneret by using a high-voltage generator (Gamma High Voltage, Ormond Beach, FL). The electrospinning process was allowed to proceed until an approximately 200 μm wall thickness was achieved. The structure of the scaffolds was characterized by using a scanning electron microscope (Hitachi TM-1000).
All the animal procedures in this study followed the National Institutes of Health guide for the care and use of Laboratory animals and were approved by the University of California Berkeley Animal Care and Use Committee. For rats, anesthesia was induced with 3% isoflurane in an induction chamber followed by subcutaneous injection of 0.05 mg/kg buprenorphine and 1 mg/kg meloxicam for analgesia. For mice, anesthesia was induced with 3% isoflurane in an induction chamber followed by subcutaneous injection of 0.1 mg/kg buprenorphine and 5 mg/kg meloxicam for analgesia. Maintenance anesthesia was with 1.5–2% isoflurane delivered by mask. Toe pinch was performed to confirm the anesthetic depth. Aseptic surgeries were performed in all the procedures. Post-surgery buprenorphine was given to the animals for analgesia. The body weight, appearance and appetite of the animals will be monitored every day. The animals were euthanized by CO2 inhalation until they ceased breathing completely and then followed by bilateral thoracotomy for rats, or cervical dislocation for mice. The samples were then collected for analysis.
Subcutaneous biomaterials implantation: Male Sprague Dawley (SD) rats with the body weight of about 100–150 g were used in the experiments. Small pieces of PLLA membrane (about 5 × 5 mm) were implanted into various subcutaneous spaces, such as abdomen, neck, groin and back. Normal SD rats of the same body weight were used as a control group. Each group had three animals.
Matrigel plug assay: Sox10+ stem cells were isolated from GFP-rats (Rat Resource & Research Center, # 0065), and the first passage of cells were used for isolating GFP+/Sox10+/P75+ cells by P75 magnetic cell separation (MACS kit, Miltenyi Biotec, 130-097-127) according to the product instructions. The GFP+/Sox10+/P75+ cells were then mixed with Matrigel (Corning) with the cell density of 2 × 106/ml and then injected to immunodeficient NSG mice (The Jackson Laboratory, # 005557) subcutaneously. After two weeks, the Matrigel plugs were harvested for histological analysis.
Mouse dorsal skinfold chamber: The procedure for implanting dorsal skinfold chamber was described previously49, with minor modifications. The GFP+/Sox10+/P75+ stem cells prepared as mentioned above were mixed with Matrigel and injected into the skinfold chamber of NSG mice by a curved 30 G needle. For two-photon microscopy, the mice were anesthetized by isoflurane and placed on a custom-made stage for imaging. One hour before imaging, dextran-Rhodamine was injected to the mice through tail vein. The z-series images were taken at the wavelength of 890 nm.
Cell culture, telomerase activity and differentiation
Sox10+ adult stem cells were isolated from subcutaneous loose connective tissue of SD rats or transgenic GFP-rats. Subcutaneous loose connective tissues were dissected and cut into small pieces and placed onto the culture dish coated with 1% CellStart (Invitrogen) to allow cells to migrate out of the tissue explants. The culture was maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% FBS, or in an optimized CEE medium, which is composed of DMEM supplemented with 2% CEE (MP Biomedical), 2% FBS, 1% N2 (Invitrogen), 2% B27 (Invitrogen), 100 nM retinoic acid (Sigma-Aldrich), 50 nM 2-mercaptoethanol (Sigma-Aldrich), 1% Penicillin/Streptomycin and 20 ng/ml bFGF (R&D Systems) based on a previous established protocol19. Telomerase activity was performed by a Quantitative Telomerase Detection kit (US Biomax) according to the manufacturer instructions. For differentiation into fibroblasts, the cells were cultured in DMEM supplemented with 10% FBS. For differentiation into myofibroblasts and SMCs, the cells were cultured in DMEM supplemented with 10% FBS and 10 ng/ml TGFβ1 (Peprotech) for two weeks. For differentiation into chondrogenic, osteogenic and adipogenic cells, the cells were cultured in specific media as described previously20,50.
Flow cytometry analysis
For flow cytometry analysis, the Sox10+ stem cells were detached by 0.2% ethylenediaminetetraacetic acid (EDTA) for about 10 min, and blocked in 1% bovine serum albumin (BSA) for 30 min on ice. The following primary antibodies were used: CD29 (555005, BD), CD44 (550974, BD), CD73 (551123, BD), CD90 (554898, BD), P75 (ab8874, Abcam), c-Kit (sc-1494, Santa Cruz Tech), CD146 (FAB3250F, R&D), CD45 (561867, BD), ADAM12 (14139-1-AP, Proteintech Group Inc.). For unconjugated primary antibodies, corresponding secondary antibodies were used. Isotype IgG was used as negative control. Propidium iodide was used to exclude dead cells. A Guava easyCyte™ Flow Cytometer was used for the analysis.
Single-cell colony formation assay
Sox10+ cells were detached and suspended in CEE medium. About 100 cells were added to each 100-mm dish in CEE medium. Medium was changed every three days. For secondary and tertiary single-cell colony formation in the medium of 10% FBS, the cells of single colonies were first washed with phosphate buffered saline (PBS), 8-mm glass cylinders with grease (Dow Corning 976 V High-Vacuum grease) on the bottom side were placed around the colonies, and TrypLE (Invitrogen) was added into the cylinders to detach the cells. The mixture of single colonies were passaged to new dishes at the density of about 100 cells per 100-mm dish in the medium with 10% FBS.
Transwell cell migration assay
24-well transwell plates (Costar, pore size: 8 μm) were used for the cell migration assay. For each well, 4 × 104 GFP+/Sox10+/P75+ stem cells isolated as mentioned above were seeded onto the top insert for 2 h in DMEM supplemented with 0.5% BSA. The top inserts were then transferred to the wells with DMEM supplemented with 0.5% BSA (control) and specific growth factors: 10 ng/ml basic fibroblast growth factor (bFGF), platelet-derived growth factor BB (PDGF-BB) and vascular endothelial growth factor (VEGF). After 5 h, the cells were fixed, stained by DAPI and the migrating cells numbers were counted by confocal microscopy. There were three repeats for each group.
Matrigel tube formation assay
GFP+/Sox10+/P75+ stem cells isolated as mentioned above were mixed with human microvascular endothelial cells (HMECs) (ratio: 0.3:1) and seeded onto the surface of Matrigel (Corning). The cells were fixed for immunostaining after overnight culture in EGM2 medium (Lonza).
Ex vivo tissue explant culture models
Rat subcutaneous connective tissue was cut into small pieces and placed in collagen I (1 mg/ml, Millipore) gel. The culture medium was Opti-MEM (Invitrogen) supplemented with 20 ng/ml bFGF.
Histology and immunostaining
Rat and mouse tissues and biomaterial samples were collected and fixed in 4% paraformaldehyde for half hour at room temperature. The animal tissue samples were then transferred to 15% and 30% sucrose overnight in cold room, and embedded in OCT for cryosection. For immunostaining, the cells were fixed with 4% paraformaldehyde for 15 min, the tissue sections were re-fixed with 4% paraformaldehyde for 10 min, before permeabilized in 0.5% Triton X-100 (Sigma-Aldrich) for 5 min. The samples were then blocked with 5% donkey serum for 1 h, incubated in primary antibodies for 2 h at room temperature, or overnight at cold room. The following primary antibodies were used: MYH11 (BT-562, Biomedical Technologies), CD31 (ab28364, abcam), Sox10 (sc-17342, Santa Cruz Biotech), Snail (sc-28199, Santa Cruz Tech), Tuj1 (MAB1637, EMD Millipore), NG2 (AB5320, EMD Millipore), ACTA2 (ab32575, abcam), FSP1 (ab27957, abcam), Vimentin (ab92547, abcam), Calponin1 (CNN1, ab46794, abcam), Smoothelin (sc-28562, Santa Cruz Tech), Myocardin (sc-34238, Santa Cruz Tech). After primary antibodies incubation, the samples were washed with 0.1% Triton for three times, incubated with corresponding AF488, 546 or 633-labeled secondary antibodies (Molecular Probes) and 4′,6-diamidino-2-phenylindole (DAPI). Fluorescence images were taken by confocal microscopy (Prairie, Zeiss LSM710 and Leica SP5-Blue). Nine cross sections were used to count Sox10+ cell number in normal tissue and around scaffold. For counting FSP1+ and ACTA2+ cells cultured in the media of CEE, 10% FBS and 10% FBS plus TGFβ1, at least nine fields of view were collected for each group. The figures were processed by Adobe Photoshop and Adobe Illustrator.
Data were reported as means ± SD, unless otherwise indicated. All experiments were repeated at least three times. Student’s t-test was used for the analysis of differences between different groups. Significance level was set as P < 0.05 or 0.01.
How to cite this article: Wang, D. et al. Sox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization. Sci. Rep. 7, 40295; doi: 10.1038/srep40295 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ratner, B. D. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 78, 211–218 (2002).
Wang, H. et al. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected]. Nat Commun 6, 10081, doi: 10.1038/ncomms10081 (2015).
Nichols, S. P., Koh, A., Storm, W. L., Shin, J. H. & Schoenfisch, M. H. Biocompatible Materials for Continuous Glucose Monitoring Devices. Chemical Reviews 113, 2528–2549, doi: 10.1021/cr300387j (2013).
Hashi, C. K. et al. Antithrombogenic Modification of Small-Diameter Microfibrous Vascular Grafts. Arteriosclerosis, Thrombosis, and Vascular Biology 30, 1621–1627, doi: 10.1161/atvbaha.110.208348 (2010).
Yu, J. et al. The effect of stromal cell-derived factor-1alpha/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration. Biomaterials 33, 8062–8074, doi: 10.1016/j.biomaterials.2012.07.042 (2012).
Lee, C. H. et al. Protein-releasing polymeric scaffolds induce fibrochondrocytic differentiation of endogenous cells for knee meniscus regeneration in sheep. Sci Transl Med 6, 266ra171, doi: 10.1126/scitranslmed.3009696 (2014).
Lee, V. K. & Dai, G. Printing of Three-Dimensional Tissue Analogs for Regenerative Medicine. Ann Biomed Eng, doi: 10.1007/s10439-016-1613-7 (2016).
Veiseh, O. et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater 14, 643–651, doi: 10.1038/nmat4290 (2015).
Bryers, J. D., Giachelli, C. M. & Ratner, B. D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng 109, 1898–1911, doi: 10.1002/bit.24559 (2012).
Madden, L. R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci USA 107, 15211–15216, doi: 10.1073/pnas.1006442107 (2010).
Kurpinski, K. T., Stephenson, J. T., Janairo, R. R. R., Lee, H. & Li, S. The effect of fiber alignment and heparin coating on cell infiltration into nanofibrous PLLA scaffolds. Biomaterials 31, 3536–3542, doi: 10.1016/j.biomaterials.2010.01.062 (2010).
Lee, B. L.-P. et al. Femtosecond laser ablation enhances cell infiltration into three-dimensional electrospun scaffolds. Acta Biomaterialia 8, 2648–2658, doi: 10.1016/j.actbio.2012.04.023 (2012).
Zeisberg, M. & Kalluri, R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 304, C216–225, doi: 10.1152/ajpcell.00328.2012 (2013).
Gabbiani, G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200, 500–503, doi: 10.1002/path.1427 (2003).
Hinz, B. et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180, 1340–1355, doi: 10.1016/j.ajpath.2012.02.004 (2012).
Kramann, R., DiRocco, D. P. & Humphreys, B. D. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. J Pathol 231, 273–289, doi: 10.1002/path.4253 (2013).
Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176, 85–97, doi: 10.2353/ajpath.2010.090517 (2010).
Dulauroy, S., Di Carlo, S. E., Langa, F., Eberl, G. & Peduto, L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 18, 1262–1270, doi: 10.1038/nm.2848 (2012).
Kramann, R. et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16, 51–66, doi: 10.1016/j.stem.2014.11.004 (2015).
Tang, Z. et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun 3, 875, doi: 10.1038/ncomms1867 (2012).
Bronner-Fraser, M. Mechanisms of neural crest cell migration. Bioessays 15, 221–230, doi: 10.1002/bies.950150402 (1993).
Hong, C. S. & Saint-Jeannet, J. P. Sox proteins and neural crest development. Semin Cell Dev Biol 16, 694–703, doi: 10.1016/j.semcdb.2005.06.005 (2005).
Hauser, S. et al. Isolation of novel multipotent neural crest-derived stem cells from adult human inferior turbinate. Stem Cells Dev 21, 742–756, doi: 10.1089/scd.2011.0419 (2012).
Tomokiyo, A. et al. A multipotent clonal human periodontal ligament cell line with neural crest cell phenotypes promotes neurocytic differentiation, migration, and survival. J Cell Physiol 227, 2040–2050, doi: 10.1002/jcp.22933 (2012).
Clewes, O. et al. Human epidermal neural crest stem cells (hEPI-NCSC)–characterization and directed differentiation into osteocytes and melanocytes. Stem Cell Rev 7, 799–814, doi: 10.1007/s12015-011-9255-5 (2011).
Li, M. et al. Multipotent neural crest stem cell-like cells from rat vibrissa dermal papilla induce neuronal differentiation of PC12 cells. Biomed Res Int 2014, 186239, doi: 10.1155/2014/186239 (2014).
Dravis, C. et al. Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells. Cell Rep 12, 2035–2048, doi: 10.1016/j.celrep.2015.08.040 (2015).
Wislet-Gendebien, S. et al. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sci 69, 2593–2608, doi: 10.1007/s00018-012-0937-1 (2012).
Shakhova, O. et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol 14, 882–890, doi: 10.1038/ncb2535 (2012).
Tang, Z., Wang, A., Wang, D. & Li, S. Smooth muscle cells: to be or not to be? Response to Nguyen et al. Circ Res 112, 23–26, doi: 10.1161/CIRCRESAHA.112.281055 (2013).
Watanabe, T., Kanda, K., Ishibashi-Ueda, H., Yaku, H. & Nakayama, Y. Autologous small-caliber “Biotube” vascular grafts with argatroban loading: A histomorphological examination after implantation to rabbits. Journal of Biomedical Materials Research Part B: Applied Biomaterials 92B, 236–242, doi: 10.1002/jbm.b.31510 (2010).
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3, 349–363, doi: 10.1038/nrm809 (2002).
Gan, Q., Yoshida, T., Li, J. & Owens, G. K. Smooth Muscle Cells and Myofibroblasts Use Distinct Transcriptional Mechanisms for Smooth Muscle α-Actin Expression. Circulation Research 101, 883–892, doi: 10.1161/circresaha.107.154831 (2007).
van der Loop, F. T., Schaart, G., Timmer, E. D., Ramaekers, F. C. & van Eys, G. J. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol 134, 401–411 (1996).
Christen, T. et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation 103, 882–888 (2001).
Chambers, R. C., Leoni, P., Kaminski, N., Laurent, G. J. & Heller, R. A. Global Expression Profiling of Fibroblast Responses to Transforming Growth Factor-β1 Reveals the Induction of Inhibitor of Differentiation-1 and Provides Evidence of Smooth Muscle Cell Phenotypic Switching. The American Journal of Pathology 162, 533–546, doi: 10.1016/S0002-9440(10)63847-3 (2003).
Tarin, D. & Croft, C. B. Ultrastructural studies of wound healing in mouse skin. II. Dermo-epidermal interrelationships. J Anat 106, 79–91 (1970).
Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat Rev Cancer 6, 392–401, doi: 10.1038/nrc1877 (2006).
Strutz, F. et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130, 393–405 (1995).
Okada, H., Danoff, T. M., Kalluri, R. & Neilson, E. G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273, F563–574 (1997).
Schneider, M., Hansen, J. L. & Sheikh, S. P. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J Mol Med (Berl) 86, 507–522, doi: 10.1007/s00109-007-0301-3 (2008).
Kriz, W., Kaissling, B. & Le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121, 468–474 (2011).
Bockmeyer, C. L. et al. Arteriolar vascular smooth muscle cell differentiation in benign nephrosclerosis. Nephrol Dial Transplant 27, 3493–3501, doi: 10.1093/ndt/gfr811 (2012).
Ambartsumian, N. et al. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20, 4685–4695, doi: 10.1038/sj.onc.1204636 (2001).
Schmidt-Hansen, B. et al. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23, 5487–5495, doi: 10.1038/sj.onc.1207720 (2004).
Semov, A. et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280, 20833–20841, doi: 10.1074/jbc.M412653200 (2005).
Chen, X. et al. Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts. Tissue Eng Part A 16, 585–594, doi: 10.1089/ten.TEA.2009.0491 (2010).
Lee, B. L. et al. Synovial stem cells and their responses to the porosity of microfibrous scaffold. Acta Biomater 9, 7264–7275, doi: 10.1016/j.actbio.2013.03.009 (2013).
Palmer, G. M. et al. In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters. Nat Protoc 6, 1355–1366, doi: 10.1038/nprot.2011.349 (2011).
Wang, A. et al. Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32, 5023–5032, doi: 10.1016/j.biomaterials.2011.03.070 (2011).
This work was supported by the grants from NIH (HL117213 and HL121450 to S.L.), UCLA startup fund (to S.L.) and Siebel Fellowship (to D.W.). X.G. as endowed Pamela and Kenneth Fong Chair. We thank Mary West in CIRM/QB3 Shared Stem Cell Facility of UC Berkeley for her technical assistance. Some of the confocal microscopy (Leica SP5-Blue) was performed at the CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA. We also thank Dr. Fan Yuan at Duke University for his help on skinfold chamber model and Dr. Yang Dan at UC Berkeley for her help on two-photon microscopy.
The authors declare no competing financial interests.
About this article
Cite this article
Wang, D., Wang, A., Wu, F. et al. Sox10+ adult stem cells contribute to biomaterial encapsulation and microvascularization. Sci Rep 7, 40295 (2017). https://doi.org/10.1038/srep40295